They may have plans to reduce the skyrocketing cost of prescription drugs, but neither candidate's proposals thus far look likely to provide substantial relief.
And one major reason is the power of the drug lobby.
Kaiser Health News reported that while Hillary Clinton does have an extensive proposal to tackle "unjustified price hikes for long-available drugs," as well as an additional proposal about high drug prices in general, Donald Trump hasn't addressed the problem with specifics other than to advocate legislative action that would let Medicare negotiate drug prices for its clients.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
